rs587778850
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000321.3(RB1):c.2520+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
RB1
NM_000321.3 splice_donor, intron
NM_000321.3 splice_donor, intron
Scores
5
1
1
Splicing: ADA: 1.000
2
Clinical Significance
Conservation
PhyloP100: 8.77
Genes affected
RB1 (HGNC:9884): (RB transcriptional corepressor 1) The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.010764263 fraction of the gene. Cryptic splice site detected, with MaxEntScore 8.5, offset of 39, new splice context is: attGTaagt. Cryptic site results in inframe change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 13-48473391-G-A is Pathogenic according to our data. Variant chr13-48473391-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 126805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RB1 | NM_000321.3 | c.2520+1G>A | splice_donor_variant, intron_variant | ENST00000267163.6 | NP_000312.2 | |||
RB1 | NM_001407165.1 | c.2520+1G>A | splice_donor_variant, intron_variant | NP_001394094.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RB1 | ENST00000267163.6 | c.2520+1G>A | splice_donor_variant, intron_variant | 1 | NM_000321.3 | ENSP00000267163.4 | ||||
RB1 | ENST00000650461.1 | c.2520+1G>A | splice_donor_variant, intron_variant | ENSP00000497193.1 | ||||||
RB1 | ENST00000643064.1 | c.192+91948G>A | intron_variant | ENSP00000496005.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1409452Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 703868
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1409452
Hom.:
Cov.:
28
AF XY:
AC XY:
0
AN XY:
703868
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Retinoblastoma Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2019 | Disruption of this splice site has been observed in several individuals affected with retinoblastoma (PMID: 12541220, 18000883, 28193182, 16595082). This variant is also described as c.2658+1G>A and g.170403G>A in the literature. ClinVar contains an entry for this variant (Variation ID: 126805). For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in RB1 are known to be pathogenic (PMID: 17096365). Experimental studies have shown that this variant disrupts mRNA splicing (PMID: 18000883). This variant is not present in population databases (ExAC no frequency). This sequence change affects a donor splice site in intron 24 of the RB1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. - |
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 27, 2018 | The c.2520+1G>A variant in RB1 has been reported in at least 2 individuals with retinoblastoma (Richter 2003, Houdayer 2008) and was absent from large populatio n studies. This variant occurs in the invariant region (+/- 1,2) of the splice c onsensus sequence and is predicted to cause altered splicing leading to an abnor mal or absent protein. However, this information is not predictive enough to det ermine pathogenicity. Functional analysis using patient cell lines demonstrated that the c.2520+1G>A variant results in skipping of exon 24 (Houdayer 2008, John son 2014). This results in a frameshift, which is predicted to lead to loss of function via nonsense mediated decay (NMD). Loss of function is an established mechanism of disease for the RB1 gene. In summary, this variant meets criteria to be classified as pathogenic for retinoblastoma in an autosomal dominant manne r. ACMG criteria applied: PVS1, PM2, PS4_Supporting. - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Diagnostic Laboratory, University of Pennsylvania School of Medicine | May 20, 2024 | Case and Pedigree Information: BILATERAL CASES:3, UNILATERAL CASES:0, TOTAL CASES:3, PEDIGREES:3. ACMG Codes Applied:PVS1, PM2, PS4SUP - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.2520+1G>A intronic pathogenic mutation results from a G to A substitution one nucleotide(s) after coding exon 24 of the RB1 gene. This variant has been reported in individual(s) with features consistent with RB1-related hereditary retinoblastoma (Rodríguez-Martín C et al. J Hum Genet, 2020 Jan;65:165-174; Richter S et al. Am J Hum Genet, 2003 Feb;72:253-69; Tsai T et al. Arch Ophthalmol, 2004 Feb;122:239-48; Houdayer C et al. Hum Mutat, 2004 Feb;23:193-202; Ambry internal data). In multiple assays testing RB1 function, this variant showed functionally abnormal results (Gámez-Pozo A et al. Hum Mutat, 2007 Dec;28:1245; Johnson BE et al. Science, 2014 Jan;343:189-193; Houdayer C et al. Hum Mutat, 2008 Jul;29:975-82). Of note, this variant is also referred to as c.2658+1G>A and g.170403G>A in the literature. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation. - |
Neoplasm Other:1
-, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Jul 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: -1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at